Denise P. Carter Buys 555,556 Shares of Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Stock

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) COO Denise P. Carter bought 555,556 shares of Quoin Pharmaceuticals stock in a transaction that occurred on Monday, December 23rd. The shares were acquired at an average price of $0.45 per share, with a total value of $250,000.20. Following the acquisition, the chief operating officer now directly owns 602,648 shares of the company’s stock, valued at $271,191.60. The trade was a 1,179.72 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Quoin Pharmaceuticals Price Performance

Shares of NASDAQ:QNRX opened at $0.55 on Monday. The company’s 50-day moving average price is $0.68 and its two-hundred day moving average price is $0.63. Quoin Pharmaceuticals, Ltd. has a one year low of $0.43 and a one year high of $6.18. The stock has a market capitalization of $2.78 million, a PE ratio of -0.14 and a beta of 1.79.

Quoin Pharmaceuticals Company Profile

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.